<DOC>
	<DOCNO>NCT00963742</DOCNO>
	<brief_summary>The objective multi-center clinical investigation determine safety effectiveness Lenstec Softec HD Posterior Chamber intraocular lens ( IOL ) follow one year post-operative assessment .</brief_summary>
	<brief_title>Lenstec Softec HD Posterior Chamber Intraocular Lens Clinical Investigational Protocol</brief_title>
	<detailed_description>The Softec HD Posterior Chamber IOL design treatment aphakia . The lens indicate primary implantation cataractous lens remove phacoemulsification circular tear capsulotomy posterior capsule intact . The intended benefit Softec HD Posterior Chamber IOL provide enhance vision .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Cataract require cataract extraction Study IOL implant 1 eye Distance BCVA 20/40 bad glare acuity bad 20/30 Ability comply study followup requirement Patients serious corneal disease , previous surgery serious systemic disease Ocular condition could impact vision cataract surgery Pregnant lactate woman Use ocular systemic medication could impact vision</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>cataract surgery</keyword>
	<keyword>IOL</keyword>
	<keyword>Intraocular lens</keyword>
</DOC>